BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19670037)

  • 1. Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients.
    Vikenes K; Melberg T; Farstad M; Nordrehaug JE
    Scand Cardiovasc J; 2010 Apr; 44(2):69-75. PubMed ID: 19670037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognostic value of creatine kinase-myocardial band mass after cardiac surgery in low-risk patients with stable angina.
    Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
    Cardiology; 2009; 113(2):122-31. PubMed ID: 19039220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
    Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
    Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic value of CK-MB and the troponins after angioplasty in patients with stable angina.
    Vikenes K; Melberg T; Farstad M; Nordrehaug JE
    Scand Cardiovasc J; 2011 Jun; 45(3):146-52. PubMed ID: 21413871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
    Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
    J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
    Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Troponin T, Troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty].
    La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M
    Cardiologia; 1997 Apr; 42(4):405-13. PubMed ID: 9244645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative levels of cardiac troponin versus CK-MB and high-sensitivity C-reactive protein for the prediction of 1-year cardiovascular outcome in patients undergoing vascular surgery.
    Kouvelos GN; Milionis HJ; Arnaoutoglou EM; Chasiotis G; Gartzonika C; Papa NK; Tzimas P; Matsagkas MI
    Coron Artery Dis; 2011; 22(6):428-34. PubMed ID: 21730823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term outcome of unprotected left main coronary angioplasty compared to the anticipated surgical risk.
    Rademacher W; Knape A; Schumm J; Ferrari M; Lauten A; Mudra H; Figulla HR
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):871-7. PubMed ID: 18603543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after surgery for acute coronary syndromes in relation to perioperative troponin T release and angina class - a prospective study in 200 patients.
    Bjessmo S; Svenarud P; Tran PK
    Thorac Cardiovasc Surg; 2009 Apr; 57(3):148-52. PubMed ID: 19330751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients.
    Yan AT; Yan RT; Tan M; Chow CM; Fitchett D; Stanton E; Langer A; Goodman SG;
    Eur Heart J; 2004 Nov; 25(22):2006-12. PubMed ID: 15541836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
    Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
    Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
    Galla JM; Mahaffey KW; Sapp SK; Alexander JH; Roe MT; Ohman EM; Granger CB; Armstrong PW; Harrington RA; White HD; Simoons ML; Newby LK; Califf RM; Topol EJ
    Am Heart J; 2006 Jan; 151(1):16-24. PubMed ID: 16368286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
    Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
    Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.
    Bar-Or D; Winkler JV; Vanbenthuysen K; Harris L; Lau E; Hetzel FW
    Am Heart J; 2001 Jun; 141(6):985-91. PubMed ID: 11376314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.